Click for Text-Only version
Back to CUA Home
The Catholic University of America - Campus Legal Clearinghouse
 

 
Collage of Pictures

Affirmative Action

ADA Compliance

Copyright

Employment

Environment

FERPA

GLB/Security

Harassment

HIPAA

Immigration

Religious Issues

Research & Patents

Student Life Issues

IDEA Scholarships

Campus Security

Tax

CLIC Home        CUA Policies        Text-Only        FedLaw        DC Law        Compliance Calendar       Compliance Partners        Links

Summary of Federal Laws

 

Research                                                                            

CUA Compliance Partners

Industrial Hygienist/Biosafety Officer

 

Federal Policy on Recombinant DNA

NIH Guidelines for Research Involving DNA Molecules

Any institution that sponsors recombinant DNA research that is covered by the National Institutes of Health (NIH) guidelines must make sure that the appropriate level of review occurs by the Institutional Biosafety Committee, and that any required petitions are submitted to the NIH.  The NIH guidelines are available online.  The most recent Federal Register notices may also be accessed at this site.

 

The IBC must have at least five members. Details on committee membership can be found in Section IV-B-2 of the NIH Guidelines. Two members must be persons not affiliated with the institution who represent the interest of the surrounding community with respect to protection of the health and safety of the environment. Registration of the IBC with NIH (Office of Biotechnology Activities) is required.

The institution must file an annual report that includes the following:


1) An updated committee roster indicating the role of each committee member and

2) Biosketches for each member of the committee. This this can be a CV or resume.

The cover letter should indicate that this info is being submitted as the IBC's annual report.

There is an ongoing obligation to notify OBA of any changes in committee membership when they occur. If changes do occur, the report should include a revised roster, with new members and their contact information and a resume.

 

The Biosafety Committee must report any significant problems or violations of the NIH Guidelines or an significant research related accidents and illnesses to NIH OBA within 30 days. Incident reporting is also a responsiblity of insitutions, Biosafety Offices, and principal investigators. Institutions may coordinate which party will make the report on behalf of the institution.
 

 

Resources

Office of Biotechnology Activities (Q and A on IBCs)
****

 

Federal Register Announcements on NIH Guidelines
*****

CUA Form for Registration of Recombinant DNA Experiments


******

 

 

 

 

 

 

 

page updated 2/18/09

updated 2/20/09 to add DNA Experiment Form
links updated 3/12/09 rab
compliance box links updated 6/3/09 rab



Last Revised 03-Jun-09 04:39 PM.